NDC 82568-0010-06 - CHILDRENS ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82568-0010
- Requested NDC
- 82568-0010-06
- Package NDCs from labels
- 82568-0010-2, 82568-0010-4, 82568-0010-8, 82568-0010-6, 82568-0010-06
- Manufacturer
- AARNA USA INC.
- Effective date
- 2025-06-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHILDRENS ACETAMINOPHEN - AARNA USA INC. | AARNA USA INC. | 2025-06-20 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82568-0010-2 | CHILDRENS ACETAMINOPHEN | 60 mL in 1 BOTTLE | SUSPENSION | 60 | 1 | |
| 82568-0010-4 | CHILDRENS ACETAMINOPHEN | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 | |
| 82568-0010-6 | CHILDRENS ACETAMINOPHEN | 473 mL in 1 BOTTLE | SUSPENSION | 473 | 1 | |
| 82568-0010-8 | CHILDRENS ACETAMINOPHEN | 236 mL in 1 BOTTLE | SUSPENSION | 236 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Maximum strength Max Cold and Sinus | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | AptaPharma Inc. | 263dae13-5f92-4505-8bcc-e903d05b9a0c | 2024-01-31 | Warnings | 362O9ITL9D |
| butalbital, acetaminophen and caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Bryant Ranch Prepack | 6a593fc7-49b0-4910-8a0c-5e718e5ff45b | 2024-01-31 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| THERAFLU POWERPODS NIGHTTIME SEVERE COLD | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 39f9feef-4bf2-4f10-9fff-22bbb1d8a471 | 2024-01-30 | Warnings | 362O9ITL9D |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 102bdcde-cb90-f248-e063-6394a90aac79 | 2024-01-30 | Warnings | M013 362O9ITL9D |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Seton Pharmaceuticals LLC | 3c5cefe3-c84e-4380-97f3-78e3fe92543a | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | 61802b27-c9ec-4386-9d44-45e8b1e558b7 | 2024-01-28 | Warnings | M013 362O9ITL9D |
| Theraflu Daytime Severe Cold and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE | Haleon US Holdings LLC | c0689223-5c90-4dbc-bbfa-f94e267504c3 | 2024-01-28 | Warnings | 362O9ITL9D |
| Excedrin Migraine Geltabs | ACETAMINOPHEN, ASPRIN, CAFFEINE | Haleon US Holdings LLC | cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8 | 2024-01-28 | Warnings | 362O9ITL9D |
| THERAFLU MULTI-SYMPTOM SEVERE COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Haleon US Holdings LLC | a4c56ca0-7785-404b-996d-137cc135f270 | 2024-01-28 | Warnings | 362O9ITL9D |
| THERAFLU NIGHTTIME SEVERE COLD AND COUGH | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 5f7f6f70-0f36-4541-89f2-d953259cdb1e | 2024-01-28 | Warnings | 362O9ITL9D |
| AGRIFEN | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | 0fde22da-cdfc-36cc-e063-6294a90a3885 | 2024-01-26 | Warnings | M013 362O9ITL9D |
| DOLODOL | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e80536f1-92cc-5bb3-e053-2995a90a9540 | 2024-01-26 | Warnings | M013 362O9ITL9D |
| No More Products | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc | 102e7dbb-06dc-f4d1-e063-6394a90aa3eb | 2024-01-26 | Warnings | PDC6A3C0OX |
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Sarati International, Inc. | 0fe10710-ac59-4fc5-e063-6294a90a48fc | 2024-01-26 | Warnings | PDC6A3C0OX |
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | f076fd33-9eaf-49b9-b0ee-6a349567c5ff | 2024-01-24 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | CVS Pharmacy, Inc. | b70beee4-407e-547c-e053-2a95a90af22a | 2024-01-24 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | 179c221d-c099-400c-b3ac-124e26947620 | 2024-01-24 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | CVS Pharmacy, Inc. | e577fdf0-85b1-1471-e053-2995a90a6fcd | 2024-01-24 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | WALMART INC. | 0035a4fd-8dd5-4534-a1b5-f510d637f721 | 2024-01-24 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.